Full Video Abstract: Evidence for Oral Semaglutide in Type 2 Diabetes

December 10, 2020
Supplements and Featured Publications, The Evidence for Oral Semaglutide in Type 2 Diabetes From a Managed Care Perspective,

This infographic to The American Journal of Managed Care® supplement, "The Evidence for Oral Semaglutide in Type 2 Diabetes From a Managed Care Perspective," describes key managed care information on the role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the management of type 2 diabetes in the United States, and appraises the clinical evidence for the first oral GLP-1RA, oral semaglutide.

Click here to read the full supplement to this video abstract.